Hrt Financial »

Vyne Therapeutics shares owned by Hrt Financial

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by Hrt Financial from 13F filings

Historical chart of Hrt Financial investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by Hrt Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by Hrt Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $23k 10k 2.29
2023-03-31 $31k 10k 3.01

More positions owned by Hrt Financial

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Merck & Co (MRK)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Workday Cl A (WDAY)
CRH Ord (CRH)
General Motors Company (GM)
Automatic Data Processing (ADP)
Microsoft Corporation (MSFT)
Raytheon Technologies Corp (RTX)
Illinois Tool Works (ITW)
Johnson Ctls Intl SHS (JCI)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)

View all positions for Hrt Financial

Top funds holding Vyne Therapeutics

Cormorant Asset Management
Eventide Asset Management
Citadel Advisors
Parkman Healthcare Partners
DSC Advisors
Palo Alto Investors
AlphaCentric Advisors
Exome Asset Management
Schonfeld Strategic Advisors
Royal Bank of Canada
ADAR1 Capital Management
Geode Capital Management
Springbok Capital Management
Vanguard Group
Susquehanna International

View all funds holding Vyne Therapeutics